Parkinson's disease is the second most prevalent neurodegenerative disease behind Alzheimer's disease. Nearly one million people have Parkinson's disease in the U.S., and 60,000 are newly diagnosed yearly.

"The question we want to answer is whether there is a benefit to exercising at the higher intensity in terms of slowing down the rate at which (Parkinson's) disease progresses. No drug has been shown to slow down the rate at which the disease progresses."

— Daniel Corcos, PhD

Learn more: [ Ссылка ]

------------------------------------------

Visit the Feinberg website: [ Ссылка ]
Listen to more podcasts: [ Ссылка ]

SUBSCRIBE: [ Ссылка ]

TWITTER: [ Ссылка ]
INSTAGRAM: [ Ссылка ]
FACEBOOK: [ Ссылка ]
LINKEDIN: [ Ссылка ]

About Northwestern University Feinberg School of Medicine:
Our mission is to impact the practice of medicine through discovery and education to improve human health.

свернуть